✦ LIBER ✦

Salvage therapy for relapsed chronic lymphocytic leukemia

✍ Scribed by Andritsos, Leslie A; Grever, Michael R

Book ID: 121273956
Publisher: Expert Reviews
Year: 2011
Tongue: English
Weight: 426 KB
Volume: 4
Category: Article
ISSN: 1747-4086
DOI: 10.1586/ehm.11.13

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Lenalidomide and Ritux

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Badoux, X. C.; Keating, M. J.; Wen, S.; Wierda, W. G.; O'Brien, S. M.; Faderl, S 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 137 KB

Methylprednisolone-rituximab is an effec

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

✍ Bowen, Deborah A.; Call, Timothy G.; Jenkins, Greg D.; Zent, Clive S.; Schwager, 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 165 KB

Salvage therapy for relapsed or refracto

Salvage therapy for relapsed or refractory acute myeloid leukemia

✍ Mangan, J. K.; Luger, S. M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 141 KB

Targeted therapy for chronic lymphocytic

Targeted therapy for chronic lymphocytic leukemia

✍ Alfonso Quintás-Cardama; Susan O’Brien 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 203 KB

Antibody Therapy for Chronic Lymphocytic

Antibody Therapy for Chronic Lymphocytic Leukemia

✍ Beth A. Christian; Thomas S. Lin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Idelalisib and Rituximab in Relapsed Chr

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

✍ Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 589 KB